Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17373905 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
Conditions: Adenocarcinoma;   Colorectal Cancer;   Ovarian Cancer;   Breast Cancer
Interventions: Biological: PANVAC-V;   Biological: PANVAC-F;   Drug: Sargramostim (GM-CSF, Leukine)

Indicates status has not been verified in more than two years